About N-[(1S,2S)-2-hydroxycyclobutyl]-5-methyl-6-(1-methylpyrazol-3-yl)-4-[[4-(1-methylpyrazol-3-yl)phenyl]methyl]pyridine-2-carboxamide;N-[(3R,4S)-3-hydroxyoxan-4-yl]-4-[[4-(2-methyl-1,3-oxazol-4-yl)phenyl]methyl]-6-pyrazol-1-ylpyridine-2-carboxamide;N-[(3R,4S)-3-hydroxyoxan-4-yl]-4-[[6-(1-methylpyrazol-4-yl)-3-pyridinyl]methyl]-6-pyrazol-1-ylpyridine-2-carboxamide
N-[(1S,2S)-2-hydroxycyclobutyl]-5-methyl-6-(1-methylpyrazol-3-yl)-4-[[4-(1-methylpyrazol-3-yl)phenyl]methyl]pyridine-2-carboxamide;N-[(3R,4S)-3-hydroxyoxan-4-yl]-4-[[4-(2-methyl-1,3-oxazol-4-yl)phenyl]methyl]-6-pyrazol-1-ylpyridine-2-carboxamide;N-[(3R,4S)-3-hydroxyoxan-4-yl]-4-[[6-(1-methylpyrazol-4-yl)-3-pyridinyl]methyl]-6-pyrazol-1-ylpyridine-2-carboxamide (PubChem CID 159241559) has the molecular formula C75H78N18O9
and a molecular weight of 1375.57 g/mol. Its IUPAC name is N-[(1S,2S)-2-hydroxycyclobutyl]-5-methyl-6-(1-methylpyrazol-3-yl)-4-[[4-(1-methylpyrazol-3-yl)phenyl]methyl]pyridine-2-carboxamide;N-[(3R,4S)-3-hydroxyoxan-4-yl]-4-[[4-(2-methyl-1,3-oxazol-4-yl)phenyl]methyl]-6-pyrazol-1-ylpyridine-2-carboxamide;N-[(3R,4S)-3-hydroxyoxan-4-yl]-4-[[6-(1-methylpyrazol-4-yl)-3-pyridinyl]methyl]-6-pyrazol-1-ylpyridine-2-carboxamide.
Frequently Asked Questions
What is the IUPAC name of N-[(1S,2S)-2-hydroxycyclobutyl]-5-methyl-6-(1-methylpyrazol-3-yl)-4-[[4-(1-methylpyrazol-3-yl)phenyl]methyl]pyridine-2-carboxamide;N-[(3R,4S)-3-hydroxyoxan-4-yl]-4-[[4-(2-methyl-1,3-oxazol-4-yl)phenyl]methyl]-6-pyrazol-1-ylpyridine-2-carboxamide;N-[(3R,4S)-3-hydroxyoxan-4-yl]-4-[[6-(1-methylpyrazol-4-yl)-3-pyridinyl]methyl]-6-pyrazol-1-ylpyridine-2-carboxamide?
The IUPAC name of N-[(1S,2S)-2-hydroxycyclobutyl]-5-methyl-6-(1-methylpyrazol-3-yl)-4-[[4-(1-methylpyrazol-3-yl)phenyl]methyl]pyridine-2-carboxamide;N-[(3R,4S)-3-hydroxyoxan-4-yl]-4-[[4-(2-methyl-1,3-oxazol-4-yl)phenyl]methyl]-6-pyrazol-1-ylpyridine-2-carboxamide;N-[(3R,4S)-3-hydroxyoxan-4-yl]-4-[[6-(1-methylpyrazol-4-yl)-3-pyridinyl]methyl]-6-pyrazol-1-ylpyridine-2-carboxamide (CID 159241559) is N-[(1S,2S)-2-hydroxycyclobutyl]-5-methyl-6-(1-methylpyrazol-3-yl)-4-[[4-(1-methylpyrazol-3-yl)phenyl]methyl]pyridine-2-carboxamide;N-[(3R,4S)-3-hydroxyoxan-4-yl]-4-[[4-(2-methyl-1,3-oxazol-4-yl)phenyl]methyl]-6-pyrazol-1-ylpyridine-2-carboxamide;N-[(3R,4S)-3-hydroxyoxan-4-yl]-4-[[6-(1-methylpyrazol-4-yl)-3-pyridinyl]methyl]-6-pyrazol-1-ylpyridine-2-carboxamide.
What is the SMILES notation for N-[(1S,2S)-2-hydroxycyclobutyl]-5-methyl-6-(1-methylpyrazol-3-yl)-4-[[4-(1-methylpyrazol-3-yl)phenyl]methyl]pyridine-2-carboxamide;N-[(3R,4S)-3-hydroxyoxan-4-yl]-4-[[4-(2-methyl-1,3-oxazol-4-yl)phenyl]methyl]-6-pyrazol-1-ylpyridine-2-carboxamide;N-[(3R,4S)-3-hydroxyoxan-4-yl]-4-[[6-(1-methylpyrazol-4-yl)-3-pyridinyl]methyl]-6-pyrazol-1-ylpyridine-2-carboxamide?
The canonical SMILES for N-[(1S,2S)-2-hydroxycyclobutyl]-5-methyl-6-(1-methylpyrazol-3-yl)-4-[[4-(1-methylpyrazol-3-yl)phenyl]methyl]pyridine-2-carboxamide;N-[(3R,4S)-3-hydroxyoxan-4-yl]-4-[[4-(2-methyl-1,3-oxazol-4-yl)phenyl]methyl]-6-pyrazol-1-ylpyridine-2-carboxamide;N-[(3R,4S)-3-hydroxyoxan-4-yl]-4-[[6-(1-methylpyrazol-4-yl)-3-pyridinyl]methyl]-6-pyrazol-1-ylpyridine-2-carboxamide is Cc1c(Cc2ccc(-c3ccn(C)n3)cc2)cc(C(=O)N[C@H]2CC[C@@H]2O)nc1-c1ccn(C)n1.Cc1nc(-c2ccc(Cc3cc(C(=O)N[C@H]4CCOC[C@@H]4O)nc(-n4cccn4)c3)cc2)co1.Cn1cc(-c2ccc(Cc3cc(C(=O)N[C@H]4CCOC[C@@H]4O)nc(-n4cccn4)c3)cn2)cn1.
What is the InChIKey of N-[(1S,2S)-2-hydroxycyclobutyl]-5-methyl-6-(1-methylpyrazol-3-yl)-4-[[4-(1-methylpyrazol-3-yl)phenyl]methyl]pyridine-2-carboxamide;N-[(3R,4S)-3-hydroxyoxan-4-yl]-4-[[4-(2-methyl-1,3-oxazol-4-yl)phenyl]methyl]-6-pyrazol-1-ylpyridine-2-carboxamide;N-[(3R,4S)-3-hydroxyoxan-4-yl]-4-[[6-(1-methylpyrazol-4-yl)-3-pyridinyl]methyl]-6-pyrazol-1-ylpyridine-2-carboxamide?
The InChIKey is KUDXLBOMOMDGSD-NJZGGWKLSA-N. The full InChI is InChI=1S/C26H28N6O2.C25H25N5O4.C24H25N7O3/c1-16-19(14-17-4-6-18(7-5-17)20-10-12-31(2)29-20)15-23(26(34)28-21-8-9-24(21)33)27-25(16)22-11-13-32(3)30-22;1-16-27-22(14-34-16)19-5-3-17(4-6-19)11-18-12-21(28-24(13-18)30-9-2-8-26-30)25(32)29-20-7-10-33-15-23(20)31;1-30-14-18(13-27-30)19-4-3-16(12-25-19)9-17-10-21(28-23(11-17)31-7-2-6-26-31)24(33)29-20-5-8-34-15-22(20)32/h4-7,10-13,15,21,24,33H,8-9,14H2,1-3H3,(H,28,34);2-6,8-9,12-14,20,23,31H,7,10-11,15H2,1H3,(H,29,32);2-4,6-7,10-14,20,22,32H,5,8-9,15H2,1H3,(H,29,33)/t21-,24-;20-,23-;20-,22-/m000/s1.
What are the key properties of N-[(1S,2S)-2-hydroxycyclobutyl]-5-methyl-6-(1-methylpyrazol-3-yl)-4-[[4-(1-methylpyrazol-3-yl)phenyl]methyl]pyridine-2-carboxamide;N-[(3R,4S)-3-hydroxyoxan-4-yl]-4-[[4-(2-methyl-1,3-oxazol-4-yl)phenyl]methyl]-6-pyrazol-1-ylpyridine-2-carboxamide;N-[(3R,4S)-3-hydroxyoxan-4-yl]-4-[[6-(1-methylpyrazol-4-yl)-3-pyridinyl]methyl]-6-pyrazol-1-ylpyridine-2-carboxamide?
N-[(1S,2S)-2-hydroxycyclobutyl]-5-methyl-6-(1-methylpyrazol-3-yl)-4-[[4-(1-methylpyrazol-3-yl)phenyl]methyl]pyridine-2-carboxamide;N-[(3R,4S)-3-hydroxyoxan-4-yl]-4-[[4-(2-methyl-1,3-oxazol-4-yl)phenyl]methyl]-6-pyrazol-1-ylpyridine-2-carboxamide;N-[(3R,4S)-3-hydroxyoxan-4-yl]-4-[[6-(1-methylpyrazol-4-yl)-3-pyridinyl]methyl]-6-pyrazol-1-ylpyridine-2-carboxamide has a molecular weight of 1375.57 g/mol, XLogP of 7.27, 18 rotatable bonds, 6 hydrogen bond donors, and 24 hydrogen bond acceptors.
Where does this data come from?
All data for N-[(1S,2S)-2-hydroxycyclobutyl]-5-methyl-6-(1-methylpyrazol-3-yl)-4-[[4-(1-methylpyrazol-3-yl)phenyl]methyl]pyridine-2-carboxamide;N-[(3R,4S)-3-hydroxyoxan-4-yl]-4-[[4-(2-methyl-1,3-oxazol-4-yl)phenyl]methyl]-6-pyrazol-1-ylpyridine-2-carboxamide;N-[(3R,4S)-3-hydroxyoxan-4-yl]-4-[[6-(1-methylpyrazol-4-yl)-3-pyridinyl]methyl]-6-pyrazol-1-ylpyridine-2-carboxamide is sourced from PubChem (CID 159241559), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).